Table 1. Demographics, health-related characteristics, systemic and ocular health comorbidities, and medication use of participants 40 years and older that were statistically significantly different between statin user and non-users.
No statin use
N=4373 (78.1%) |
Using statins
N=1231 (21.9%) |
||||
---|---|---|---|---|---|
Mean or %* | SE | Mean or %* | SE | P-value† | |
Demographics | |||||
Gender | |||||
Female | 54.0% | 0.8% | 46.0% | 1.8% | 0.0019 |
Race | 0.0009 | ||||
Mexican | 6.0% | 0.8% | 3.1% | 0.6% | |
Other Hispanic | 3.5% | 0.7% | 2.2% | 0.5% | |
Non-Hispanic White | 76.0% | 2.2% | 82.1% | 1.9% | |
Non-Hispanic Black | 10.1% | 1.3% | 7.7% | 1.3% | |
Other and multiracial | 4.7% | 0.7% | 5.0% | 1.0% | |
Education | 0.0012 | ||||
<9th grade | 6.6% | 0.6% | 8.9% | 1.5% | |
9th grade—less than HS graduate | 11.2% | 0.9% | 10.3% | 1.4% | |
HS graduate or GED equivalent | 25.3% | 1.0% | 30.9% | 1.7% | |
Some college | 29.4% | 1.1% | 24.2% | 1.9% | |
College graduate and beyond | 27.7% | 1.8% | 25.8% | 2.2% | |
Annual household income ($) | 0.0005 | ||||
<$20 000 | 13.9% | 0.9% | 14.9% | 1.6% | |
$20 000–$44 999 | 25.3% | 1.3% | 32.8% | 2.1% | |
$45 000–$74 999 | 22.9% | 1.1% | 20.3% | 1.6% | |
$75 000 and up | 35.7% | 2.0% | 29.3% | 2.5% | |
>$20 000 | 2.3% | 0.4% | 2.9% | 0.8% | |
Health-related behaviors | |||||
Smoking | <0.0001 | ||||
Current | 22.0% | 1.3% | 15.1% | 1.7% | |
Past | 28.2% | 1.1% | 42.1% | 1.7% | |
Never | 49.9% | 1.4% | 42.9% | 2.1% | |
Systemic and ocular health conditions | |||||
General health condition | <0.0001 | ||||
Excellent or Good | 45.1% | 1.4% | 35.5% | 2.0% | |
Fair | 37.5% | 0.9% | 40.8% | 1.5% | |
Poor or very poor | 17.6% | 1.0% | 23.8% | 1.7% | |
Stroke | 3.3% | 0.4% | 7.7% | 0.9% | <0.0001 |
Visual comorbidities | |||||
History of cataract extraction | 9.9% | 0.5% | 34.3% | 3.7% | <0.0001 |
AMD | |||||
Diagnosed with AMD | 5.8% | 0.5% | 9.9% | 0.2% | 0.0003 |
All means, proportions, and SE are weighted estimates of the US population characteristics, taking into account NHANES' complex sampling design.
All P-values are unadjusted. P-values were calculated using Wald test for continuous variables, and design-adjusted Rao–Scott Pearson χ2 test for categorical variables.